Markets›Health care›MRK

Merck

MRK
148.78
+0.80 (+0.54%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Balance sheet (USD) Q2 2026
ended Jun 30, 2026
Q1 2026
ended Mar 31, 2026
Q4 2025
ended Dec 31, 2025
Q3 2025
ended Sep 30, 2025
Q2 2025
ended Jun 30, 2025
Q1 2025
ended Mar 31, 2025
Q4 2024
ended Dec 31, 2024
Q3 2024
ended Sep 30, 2024
Cash and equivalents 6.85B5.33B14.56B18.17B8.01B8.63B13.24B14.59B
Short-term investments 292.00M375.00M045.00M615.00M599.00M447.00M0
Receivables 12.56B12.21B11.78B12.12B11.85B10.79B10.28B11.38B
Inventory 6.21B6.48B6.66B6.44B6.60B6.20B6.11B6.24B
Total current assets 36.68B35.02B43.52B47.56B37.06B35.50B38.78B40.36B
Property, plant and equipment 25.74B25.43B25.32B25.64B25.24B24.79B23.78B23.45B
Goodwill and intangibles 46.56B47.33B48.26B36.90B36.78B37.44B38.04B38.71B
Total assets 129.80B128.69B136.87B129.55B117.52B115.12B117.11B117.53B
Accounts payable 3.83B3.86B4.40B4.15B3.89B3.78B4.08B3.59B
Total current liabilities 27.73B26.95B28.33B28.63B26.04B25.17B28.42B29.59B
Long-term debt 51.08B46.67B46.75B39.97B33.97B33.48B34.46B34.98B
Total liabilities 87.87B82.81B84.26B77.70B68.53B66.79B70.79B73.03B
Retained earnings 63.27B66.72B73.08B72.23B68.48B66.10B63.07B61.38B
Shareholders' equity 41.93B45.88B52.61B51.85B48.99B48.34B46.31B44.50B
Total debt 53.91B49.12B49.34B41.37B35.40B34.84B37.11B38.13B
Net debt 47.06B43.79B34.77B23.20B27.39B26.21B23.87B23.54B

From Merck's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.